August 14, 2012, 4:10PM

By Richard Folkers

Posted in: Scientist Spotlight | lymphoma

Tags: scientist

Louis Staudt, M.D., Ph.D., is the deputy chief of the Metabolism Branch in NCI’s Center for Cancer Research. In this video from March 2012, Staudt discusses the basic biology of targeted therapy for Diffuse B-cell Lymphoma and about ibrutinib, a drug with a high degree of efficacy—and only modest side effects—in the treatment of the ABC form of Diffuse B-cell Lymphoma.

 Print This Post